HighMark Wealth Management’s LianBio American Depositary Shares LIAN Stock Holding History

HighMark Wealth Management’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	-$447	–	620
2023 Q4	$447	Buy	+100	New	+$344	﹤0.01%	537

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

HighMark Wealth Management's LIAN Position: Q1 2024 in Review

HighMark Wealth Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 100 shares — an estimated $447 sold.

HighMark Wealth Management first reported a position in LIAN in Q4 2023 and held it in 1 quarter. The position peaked at $447 in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

HighMark Wealth Management reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
HighMark Wealth Management sold 100 LianBio American Depositary Shares shares in Q1 2024, an estimated $447.
HighMark Wealth Management first reported a position in LianBio American Depositary Shares in Q4 2023 and held it in 1 quarter.
HighMark Wealth Management's LianBio American Depositary Shares position peaked at $447 in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on HighMark Wealth Management's 13F filing for Q1 2024, filed 29 Apr 2024.